Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00137111 · OUTCOME

Overall Event-free Survival (EFS)

Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia · Source last updated 2020-09-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of Participants
Interval / dispersion
Not reported
Time frame
Median follow-up time (range) 5.6 (1.3 to 8.9) years

What was measured

EFS was measured from the start of on-study to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Failure to enter remission was considered an event at time zero. Measurement was determined by Kaplan-Meyer estimate.

Analysis population: 498 enrolled patients were eligible for analysis to estimate the overall event-free survival of children at least one year of age at diagnosis who are treated with risk-directed therapy.

Groups in this outcome

Total Therapy

Total therapy applies to all eligible patients.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Total Therapy498

Reported measurements

Source class 1
Values in Percentage of Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Total Therapy87.3Not reported.831.901Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        .831
        upper Limit
        .901
        value
        87.3
denoms
  1. counts
    1. group Id
      OG000
      value
      498
    units
    Participants
description
EFS was measured from the start of on-study to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Failure to enter remission was considered an event at time zero. Measurement was determined by Kaplan-Meyer estimate.
groups
  1. description
    Total therapy applies to all eligible patients.
    id
    OG000
    title
    Total Therapy
param Type
NUMBER
population Description
498 enrolled patients were eligible for analysis to estimate the overall event-free survival of children at least one year of age at diagnosis who are treated with risk-directed therapy.
reporting Status
POSTED
time Frame
Median follow-up time (range) 5.6 (1.3 to 8.9) years
title
Overall Event-free Survival (EFS)
type
PRIMARY
unit Of Measure
Percentage of Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice